Peptide therapy has emerged as an area of growing interest within integrative and functional medicine. As short chains of amino acids that serve as signaling molecules in the body, peptides are being studied for a wide range of potential applications, from supporting recovery to influencing hormone regulation. This guide provides an overview of what peptide therapy involves, how it is administered, and what individuals should consider when exploring this area.
What Is Peptide Therapy?
Peptide therapy refers to the clinical use of specific peptide compounds, typically administered under the supervision of a licensed healthcare provider. The human body naturally produces thousands of peptides that regulate various physiological processes, including immune function, hormone release, tissue repair, and metabolism. Therapeutic peptide protocols aim to supplement or modulate these natural processes using targeted peptide compounds.
It is important to distinguish between FDA-approved peptide medications and compounded peptide preparations. Some peptides, such as certain growth hormone-releasing peptides, have gone through formal regulatory approval processes. Many others used in clinical settings are prepared by compounding pharmacies and have not undergone the same level of regulatory scrutiny. This distinction matters for understanding both the evidence base and the legal landscape surrounding peptide therapy.
How Peptides Are Administered
Peptides can be delivered through several routes, each with different characteristics in terms of bioavailability, convenience, and applicability:
Subcutaneous Injection
The most common administration method for many research peptides involves subcutaneous injection, typically into the abdominal fat tissue or the fatty tissue of the thigh. This route generally offers good bioavailability and relatively predictable absorption. Many providers teach patients to self-administer these injections at home after initial instruction. For more details, see our Administration Guide.
Oral Administration
Some peptides are available in oral forms, including capsules and tablets. However, oral bioavailability is a significant challenge for most peptides because digestive enzymes break down amino acid chains before they can be absorbed. Certain peptides, such as BPC-157, have been studied in oral form with some researchers reporting activity via this route, though the evidence remains preliminary.
Nasal Sprays
Intranasal delivery bypasses the digestive system and can provide relatively rapid absorption through the nasal mucosa. This route has been studied for certain peptides, particularly those targeting neurological or hormonal pathways. Bioavailability varies significantly depending on the specific peptide and formulation.
Topical Application
Topical peptide formulations, including creams and transdermal patches, are used primarily for localized applications such as skin repair or wound healing. Absorption through the skin barrier is limited for most peptides, which restricts this route to specific use cases where local action is sufficient.
Finding a Qualified Provider
Perhaps the most critical step for anyone considering peptide therapy is finding a qualified, licensed healthcare provider with appropriate expertise. This is not an area where self-administration without medical oversight is advisable. Key considerations include:
- Medical credentials: Look for licensed physicians (MD or DO), nurse practitioners, or physician assistants with specific training in peptide therapy, functional medicine, or anti-aging medicine.
- Board certifications: Certifications from organizations such as the American Academy of Anti-Aging Medicine (A4M) or the Institute for Functional Medicine (IFM) can indicate specialized training, though they are not a guarantee of expertise.
- Compounding pharmacy relationships: Reputable providers typically work with licensed, accredited compounding pharmacies (such as those accredited by PCAB or registered with state boards) to ensure product quality and purity.
- Transparent communication: A trustworthy provider should be willing to discuss the evidence level for any recommended peptide, acknowledge limitations in the research, and explain both potential benefits and risks.
For a more detailed discussion, see our Finding a Provider Guide.
What an Initial Consultation Involves
A thorough initial consultation for peptide therapy typically includes several components:
- Comprehensive health history: The provider should review your complete medical history, current medications, supplements, and any existing conditions that might affect peptide therapy suitability.
- Baseline lab work: Blood panels are commonly ordered to establish baseline hormone levels, metabolic markers, inflammatory markers, and organ function indicators. These serve as reference points for monitoring.
- Goals discussion: The provider should understand your specific health goals and set realistic expectations about what peptide therapy may or may not achieve based on current evidence.
- Risk assessment: Any contraindications, potential drug interactions, and individual risk factors should be discussed before initiating therapy.
- Protocol planning: If therapy is appropriate, the provider will outline a specific protocol, including which peptides, dosing schedules, administration routes, and duration of treatment cycles.
Common Therapy Protocols
Peptide therapy protocols vary widely depending on the specific compounds used and the clinical goals. Some general patterns include:
Growth hormone-releasing peptides such as sermorelin and ipamorelin are often administered in cycles, with periods of active use followed by breaks. These protocols typically involve daily subcutaneous injections, often timed around sleep to align with natural growth hormone release patterns.
Recovery-oriented peptides such as BPC-157 may be used for defined treatment courses, often ranging from several weeks to a few months, targeted at specific injury recovery goals.
Combination protocols sometimes involve multiple peptides used concurrently, though evidence for specific combinations is generally limited to preclinical research and clinical observation rather than controlled trials.
Monitoring and Lab Work
Responsible peptide therapy requires ongoing monitoring. Follow-up lab work is typically scheduled at regular intervals, often every 4 to 12 weeks during active therapy, to track relevant biomarkers and assess for any adverse effects. Key markers commonly monitored include:
- IGF-1 levels (for growth hormone-releasing peptides)
- Complete blood count and metabolic panel
- Liver and kidney function markers
- Fasting glucose and insulin levels
- Inflammatory markers such as C-reactive protein
- Hormone panels relevant to the specific therapy
Any provider who does not require or recommend follow-up lab work should be viewed with caution, as monitoring is essential for safe peptide therapy.
Cost Considerations
Peptide therapy is generally not covered by insurance, as most compounded peptide preparations fall outside standard pharmaceutical coverage. Costs can vary significantly based on:
- The specific peptides prescribed and their dosing requirements
- The compounding pharmacy used and the formulation complexity
- Provider consultation and follow-up fees
- Required lab work and monitoring frequency
- Duration of therapy protocols
Monthly costs for peptide therapy can range from a few hundred to over a thousand dollars depending on these factors. Individuals should discuss all costs upfront with their provider and be wary of pricing that seems unusually low, as this may indicate quality or sourcing concerns.
Questions to Ask Your Provider
Before starting any peptide therapy protocol, consider asking the following questions:
- What is the evidence base for the peptide you are recommending? Are there human clinical trials, or is the evidence primarily from animal studies?
- What are the known side effects and risks associated with this peptide?
- Is this peptide FDA-approved or compounded? Where is it sourced?
- What monitoring and lab work will be required during therapy?
- How will we measure whether the therapy is working?
- What is the expected duration of therapy, and what happens after the protocol ends?
- Are there any contraindications with my existing medications or conditions?
A provider who is transparent, evidence-informed, and willing to discuss limitations is more likely to deliver safe, responsible care.
The Regulatory Landscape
The regulatory status of peptides is evolving. In recent years, the FDA has increased scrutiny of compounding pharmacies producing peptide preparations, and certain peptides have been added to restricted or banned lists. Individuals considering peptide therapy should stay informed about the current legal and regulatory status of any compounds they are using. Working with a licensed provider and accredited pharmacy is the best way to navigate this complex landscape.
Peptide therapy represents an evolving area of medicine with genuine scientific interest and potential, but it is not without risks, uncertainties, and regulatory complexities. Approaching it with informed skepticism, proper medical oversight, and realistic expectations is essential.